Long-term survivors of breast cancer are at a slightly decreased risk of stroke or transient ischemic attacks, with the exception of those who received hormone therapy or had hypertension or high cholesterol, according to the results of a study published in the Dec. 1 issue of the Journal of Clinical Oncology.
Long-term survivors of breast cancer are at a slightly decreased risk of stroke or transient ischemic attacks, with the exception of those who received hormone therapy or had hypertension or high cholesterol, according to the results of a study published in the Dec. 1 issue of the Journal of Clinical Oncology.
Flora E. van Leeuwen, PhD, of the Netherlands Cancer Institute in Amsterdam, and colleagues examined the treatment-specific incidence of stroke and transient ischemic attack in 4,414 women who were 10-year survivors of early-stage breast cancer.
After a median follow-up of 18 years, the researchers found that the standardized incidence ratios for stroke and transient ischemic attack were reduced compared with the general population (0.8 for each). However, women who had received hormonal treatment or who had hypertension or hypercholesterolemia had a significantly higher risk of stroke (hazard ratios 1.9, 2.1, and 1.6, respectively). There was no increased risk of stroke after irradiation of the supraclavicular nodes.
Hooning MJ, Dorresteijn LD, Aleman BM, et al. Decreased risk of stroke among 10-year survivors of breast cancer. J Clinl Oncol. 2006;24:5388-5394.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More